Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.5M
-
Number of holders
-
158
-
Total 13F shares, excl. options
-
25.2M
-
Shares change
-
+261K
-
Total reported value, excl. options
-
$548M
-
Value change
-
+$5.43M
-
Put/Call ratio
-
0.25
-
Number of buys
-
84
-
Number of sells
-
-70
-
Price
-
$21.77
Significant Holders of CASTLE BIOSCIENCES INC - Common Stock (CSTL) as of Q2 2024
185 filings reported holding CSTL - CASTLE BIOSCIENCES INC - Common Stock as of Q2 2024.
CASTLE BIOSCIENCES INC - Common Stock (CSTL) has 158 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.2M shares
of 28.5M outstanding shares and own 88.31% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.04M shares), WASATCH ADVISORS LP (2.33M shares), VANGUARD GROUP INC (1.58M shares), PRINCIPAL FINANCIAL GROUP INC (1.5M shares), Bellevue Group AG (1.22M shares), Portolan Capital Management, LLC (1.21M shares), Granahan Investment Management, LLC (1.06M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (875K shares), Soleus Capital Management, L.P. (854K shares), and DIMENSIONAL FUND ADVISORS LP (810K shares).
This table shows the top 158 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.